Related Experiment Video
Updated: Apr 11, 2026

08:25
Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
12.9K
Circular RNA: A new star of noncoding RNAs
Shibin Qu1, Xisheng Yang1, Xiaolei Li1
1Department of Hepatobiliary Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Cancer Letters
|June 9, 2015
Summary
Circular RNAs (circRNAs) are a novel RNA type forming closed loops. These stable molecules regulate gene expression and show potential as disease biomarkers.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Circular RNAs (circRNAs) are a distinct class of RNA molecules characterized by a covalently closed loop structure.
- They are abundant in the eukaryotic transcriptome and generated through specific biogenesis pathways involving complementary sequences or RNA-binding proteins.
- CircRNAs possess unique properties including stability, conservation across species, and cell-type-specific expression patterns.
Purpose of the Study:
- To review the formation, properties, and diverse functions of circRNAs.
- To explore the emerging roles of circRNAs in various diseases, including cancer and neurological disorders.
- To highlight the potential of circRNAs as diagnostic and predictive biomarkers.
Main Methods:
- Literature review of recent studies on circRNA biology and disease association.
- Analysis of circRNA biogenesis mechanisms, including splicing and regulatory roles.
- Compilation of evidence on circRNA involvement in pathological conditions.
Main Results:
- CircRNAs function as microRNA sponges, regulate splicing and transcription, and modify parental gene expression.
- Aberrant circRNA expression is observed in diseases such as colorectal cancer and pancreatic ductal adenocarcinoma.
- CircRNAs demonstrate potential as biomarkers for disease diagnosis and prognosis.
Conclusions:
- CircRNAs represent a significant area of research in RNA biology with broad implications for life processes.
- Understanding circRNA functions is crucial for developing novel therapeutic strategies and diagnostic tools.
- Further investigation into circRNAs will likely uncover their extensive involvement in health and disease.
Related Concept Videos
Ribosomal RNA Synthesis
15.3K
Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
15.3K
Ribosomal RNA Synthesis
4.9K
4.9K
lncRNA - Long Non-coding RNAs
10.2K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K
lncRNA - Long Non-coding RNAs
3.9K
3.9K
RNA Interference
28.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.8K
RNA Interference
7.9K
7.9K

